Literature DB >> 19320707

The great cannabis classification debacle: what are the likely consequences for policing cannabis possession offences in England and Wales?

Paul J Turnbull1.   

Abstract

The British government downgraded cannabis from a Class B to a Class C drug in 2004; but in 2008 it reversed this decision,and cannabis is due to be reclassified back to Class B in January 2009. In this Harm Reduction Digest, Paul Turnbull assesses the impact of reclassification to Class B focusing on policing and the legitimacy of drug law. The government cited the availability of stronger strains of cannabis and a large rise in the number of UK-based "cannabis farms" as the reasons for this decision.This is set against a backdrop of a trend of declining levels of use in the UK and a number of jurisdictions throughout the world adopting civil rather than criminal procedures to deal with cannabis possession offences. It concludes that tougher penalties for cannabis possession will have little deterrent effect on use and that the focus of law enforcement is likely to continue to fall disproportionately on young men from black and minority ethnic groups. Turnbull concludes that a better approach would be to use targeted public health approaches to reduce cannabis use and harm.

Entities:  

Mesh:

Year:  2009        PMID: 19320707     DOI: 10.1111/j.1465-3362.2008.00045.x

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  2 in total

1.  Illegal substance use among Italian high school students: trends over 11 years (1999-2009).

Authors:  Sabrina Molinaro; Valeria Siciliano; Olivia Curzio; Francesca Denoth; Stefano Salvadori; Fabio Mariani
Journal:  PLoS One       Date:  2011-06-10       Impact factor: 3.240

2.  Mediating Effects of Global Negative Effect Expectancies on the Association between Problematic Cannabis Use and Social Anxiety.

Authors:  Maria Di Blasi; Paola Cavani; Laura Pavia; Crispino Tosto; Sabina La Grutta; Rosa Lo Baido; Cecilia Giordano; Adriano Schimmenti
Journal:  Front Psychiatry       Date:  2017-11-22       Impact factor: 4.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.